Areete Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.64 Cr
- Revenue Growth 4.39%
- Profit Growth -25.19%
- Ebitda -8.51%
- Net Worth 22.27%
- Total Assets 25.52%
About Areete Life Science
Areete Life Science Private Limited (ALSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 January 2007 and has a history of 18 years and one month. Its registered office is in Nanganallur, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹2.64 Cr.
Senthilkumar Kulasekaran and Anandhalakshmi Ramukkannu serve as directors at the Company.
Company Details
- Location
Nanganallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U02423TN2007PTC062153
- Company No.
062153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2007
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Healthcare
Who are the key members and board of directors at Areete Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Senthilkumar Kulasekaran  | Director | 24-Jan-2007 | Current |
| Anandhalakshmi Ramukkannu | Director | 24-Jan-2007 | Current |
Financial Performance of Areete Life Science.
Areete Life Science Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.39% increase. The company also saw a substantial fall in profitability, with a 25.19% decrease in profit. The company's net worth Soared by an impressive increase of 22.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Areete Life Science?
In 2023, Areete Life Science had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹26.38 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 2.50 Cr
- Canara Bank : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2023 | Sidbi | ₹1.00 Cr | Open |
| 03 Jun 2020 | Sidbi | ₹1.50 Cr | Open |
| 29 Jun 2012 | Canara Bank | ₹1.00 M | Open |
| 24 Feb 2007 | Canara Bank | ₹0.38 M | Open |
How Many Employees Work at Areete Life Science?
Areete Life Science has a workforce of 44 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Areete Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Areete Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.